Edwardsiella tarda is an uncommon enteric bacterium which has been found generally in animal hosts and occasionally in human feces. Three cases of extraintestinal infection caused by E. tarda which are described herein include a typhoid-like illness, peritonitis with sepsis, and cellulitis from a wound acquired while fishing. The microbiology of E. tarda and the previous reports of infection due to this organism are reviewed.
Edwardsiella tarda is an uncommon enteric bacterium which has been found generally in animal hosts and occasionally in human feces. Three cases of extraintestinal infection caused by E. tarda which are described herein include a typhoid-like illness, peritonitis with sepsis, and cellulitis from a wound acquired while fishing. The microbiology of E. tarda and the previous reports of infection due to this organism are reviewed.
Human infections due to the bacterium Edwardsiella tarda have been reported only infrequently; cases of extraintestinal infection appear to be particularly rare (4, 6, 11, 12, 15, 17, 19, 23, 25, 27) . Three cases of extraintestinal infection due to E. tarda were documented in an 8-month period at the Texas Medical Center. Two patients had sepsis, and one had a wound infection. These 3 cases are described, and 17 previously reported cases of extraintestinal infection with this organism are reviewed.
Case Reports
Case 1. A 46-year-old Latin American male was hospitalized for fever and abdominal complaints. About 6 weeks earlier the patient had visited his wife in Mexico. At that time she had a typhoid-like illness. Five days before admission, the patient developed headache and cough, followed by lower abdominal pain, nausea, minimal diarrhea, and fever. On admission he was febrile and hypotensive. His abdomen was tender without rigidity. The hematocrit was 44%, and the leukocyte count was 2,400/mm3 with a polymorphonuclear cell predominance. Liver function studies and urinalysis were normal. The presumptive diagnosis was typhoid fever, and the patient was treated with chloramphenicol and tobramycin with rapid improvement. Cultures of blood and feces grew E. tarda, and the antibiotic therapy was changed to ampicillin. Comment RESULTS The biochemical identification pattern as indicated by the API system was identical for the isolates from our three cases (API 4544000, analytical profile index of Analytab Products, Plainsville, N.J.) and conforms to published criteria for the identification of E. tarda (8) . These motile gram-negative bacilli were oxidase negative and nitrate positive. They decarboxylated ornithine and lysine, fermented glucose but not other tested carbohydrates, and formed H2S and indole; the tests for growth on citrate, urea deaminase, and acetoin formation were negative. The biochemical reactions for E. tarda and some Salmonella sp. on commonly used screening media for enteric pathogens (e.g., triple sugar iron, lysine iron, or urea agars) are similar, as is their appearance on differential enteric media. It may be significant that the isolations were made from specimens for which a complete identification is routinely performed. None of the strains reacted in the Salmonella typing serum. Most strains of E. tarda are sensitive to ampicillin, chloramphenicol, tetracycline, and aminoglycosides but not to colistin (2, 6, 15, 18, 20, 29) ; our isolates showed this pattern by KirbyBauer and microtiter methods (Table 1 ). To our knowledge only four colistin-sensitive strains have been reported (4, 16, 17, 27) , and two of these reports (16, 27 ) occurred before routine Co-trimoxazole (trimetho-0.5/9.5 0.5/9.5 0.5/9.5 prim-sulfamethoxazole) Penicillin R aS, Susceptible; R, resistant.
use of standardized sensitivity testing. The high level of colistin resistance has been suggested as an aid in isolating and identifying the organism (22) . DISCUSSION E. tarda, a recently described member of the family Enterobacteriaceae (9, 16, 26) , exists widely in nature, being isolated from fish (1, 30) , lizards (28) , snakes (14, 17, 26) , sea mammals (7), cattle (5), swine (24) , and the environment (30) . The rate of isolation of this organism from human fecal specimens has ranged from nil for an urban population in Panama (17) and asymptomatic subjects elsewhere (2, 20) up to about 1% in rural Panamanians (17) , Indian children with diarrhea (2), or Zairese with gastroenteritis (20) . Of those people from whose feces this organism has been isolated, the percent with diarrhea has varied from 25% (17) to over 75% (4, 9, 20) . The rest were asymptomatic, possibly showing analogy to the carrier state for salmonellosis. In two populations a significant association between E. tarda and Entamoeba histolytica was noted (10, 20) .
Although the most common manifestations of infection due to E. tarda are symptoms of gastrointestinal disease, a number of serious, extraintestinal infections have been reported; these are summarized in Table 2 . In six cases trauma was followed by direct inoculation of bacteria causing abscess formation or cellulitis (cases 3 to 8); three of these cases resulted from waterassociated accidents. In cases 2, 9, and 10 infection probably was subsequent to escape of bacteria from the bowel and spread into adjacent tissues. Four patients developed liver abscess or cholangitis with E. tarda as the sole or predominant pathogen (cases 11 to 14). Nine patients had sepsis without an identifiable anatomic lesion in the bowel; three of these had an underlying condition such as immunological immaturity or connective tissue disorders with steroid therapy or malignancy which might have predisposed them to sepsis, and the patient with endocarditis had preexisting mitral valve disease. A typhoid-like illness, sometimes with hematogenous seeding of other areas, seemed to be present in at least seven cases; in two of these patients meningitis was also documented. Our patient (case 1) had the most characteristically typhoid-like illness of any described to date.
E. tarda is susceptible in vitro to nearly all antibiotics that are used to treat serious gramnegative infections. Our patients received a variety of antibiotics; patients 1 and 3 recovered with ampicillin therapy, and death in case 2 was related to consequences of sepsis. Three septic patients who recovered (cases 11, 16, and 17) received both an aminoglycoside and a betalactam antibiotic, whereas only one of the six who died (case 14) received this therapy.
Although extraintestinal human infection with E. tarda has been reported only infrequently, the recent identification of three such cases at one medical center within 8 months, each representing a major syndrome caused by this organism, suggests that better isolation techniques or methods of identification may be leading to increasing recognition of this organism. The possibility that its real incidence has increased cannot be excluded.
